The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Terminated
One of the principal investigators has moved to a different institution
Other terminated trials from McGill University Health Centre/Research Institute of the McGill University Health Centre
A observational or N/A phase clinical study on Ventilator Associated Pneumonia, this trial is terminated or withdrawn. The trial is conducted by McGill University Health Centre/Research Institute of the McGill University Health Centre and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Oct 2019 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Oct 2019 [monthly]
Terminated
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- McGill University Health Centre/Research Institute of the McGill University Health Centre
For direct contact, visit the study record on ClinicalTrials.gov .